US tariffs pose threat to India's pharma sector

The tariffs proposed by the United States on generic medicines, featuring a 200 percent duty by 2029, not only represent a medium-term risk to India's $9.7 billion pharmaceutical export market but also hurt US patients, analysts said.

Raccontata daglobal.chinadaily.com.cn